AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. APLT
  4. [SCHEDULE 13G/A] Applied Therapeutics, Inc. SEC Filing

[SCHEDULE 13G/A] Applied Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source:

Stock APLT logo
Applied Therapeutics

NASDAQ:APLT

APLT Rankings

#5057 Ranked by Market Cap
N/A Ranked by Dividends

APLT Latest News

Aug 13, 2025
Applied Therapeutics Reports Second Quarter 2025 Financial Results
Jun 17, 2025
Applied Therapeutics Announces Key Leadership Appointments
May 18, 2025
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
May 13, 2025
Applied Therapeutics Reports First Quarter 2025 Financial Results
May 9, 2025
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

APLT Latest SEC Filings

Aug 13, 2025
[10-Q] Applied Therapeutics, Inc. Quarterly Earnings Report
Aug 13, 2025
[8-K] Applied Therapeutics, Inc. Reports Material Event
Jul 29, 2025
[SCHEDULE 13G/A] Applied Therapeutics, Inc. SEC Filing
Jul 3, 2025
[Form 4] Applied Therapeutics, Inc. Insider Trading Activity

APLT Stock Data

63.58M
132.64M
5.7%
82.24%
9.36%
Biotechnology
Pharmaceutical Preparations
United States
NEW YORK